Trials / Completed
CompletedNCT04108351
Development and Validation of a Driving Simulator for Evaluating the Residual Effects of Drugs on Driving Performance - Sensitivity Analysis Using Zopiclone As a Positive Control
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Taisho Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 21 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to confirm of assay sensitivity of Driving Simulator by positive control
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Road-tracking test | Driving with simulator program for SDLP measurement |
| OTHER | Car-following test | Intervention Description: Driving with simulator program for DCV measurement |
| OTHER | Harsh-braking test | Driving with simulator program for BRT measurement |
Timeline
- Start date
- 2019-10-07
- Primary completion
- 2020-02-11
- Completion
- 2020-02-11
- First posted
- 2019-09-30
- Last updated
- 2025-02-28
Locations
2 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT04108351. Inclusion in this directory is not an endorsement.